Skip to main content

Advertisement

Log in

Altered catecholamine synthesis and degradation in the epidermis of patients with atopic eczema

  • Original paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract Patients with atopic eczema have significantly higher norepinephrine levels in plasma than healthy controls. In addition, significantly higher levels of the essential cofactor (6R)-l-erythro-5,6,7,8-tetrahydrobiopterin (6BH4) were found in this patient group. Cell extracts from epidermal suction blister roofs revealed only half the normal activity of phenylethanolamine-N-methyl transferase (PNMT) together with a threefold induction of the norepinephrine-degrading enzyme monoamine oxidase A (MAO-A). Taken together, these results support earlier observations of a defective catecholamine/adrenoceptor signal in patients with atopic eczema.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 9 December 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schallreuter, K., Pittelkow, M., Swanson, N. et al. Altered catecholamine synthesis and degradation in the epidermis of patients with atopic eczema. Arch Dermatol Res 289, 663–666 (1997). https://doi.org/10.1007/s004030050258

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004030050258

Navigation